[Lipodystrophy and antiretroviral agents]

Rev Clin Esp. 1999 Aug;199(8):485-6.
[Article in Spanish]
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / metabolism
  • Alkynes
  • Anti-HIV Agents / therapeutic use
  • Benzoxazines
  • Cyclopropanes
  • HIV Protease Inhibitors / adverse effects*
  • HIV-1*
  • Humans
  • Hyperlipidemias / etiology
  • Lipodystrophy / chemically induced*
  • Nevirapine / therapeutic use
  • Oxazines / therapeutic use
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Syndrome

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • HIV Protease Inhibitors
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • Nevirapine
  • efavirenz